Drug class · Infectious disease
Vaccines Drug Codes & NDCs
Products in the FDA's vaccine class. Vaccines are usually reported with a CPT vaccine product code plus an immunization administration code, not with a J-code.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tenivacclostridium tetani toxoid antigen (formaldehyde inactivated) and corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL; Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 2 [Lf]/.5mL | Injection, SuspensionIntramuscular | A-S Medication Solutions | 50090-2062 |
| Tice Bcgbacillus calmette-guerin | Bacillus calmette-guerin substrain tice live antigen 50 mg/50mL | Powder, For suspensionIntravesical | Merck Sharp & Dohme LLC | 0052-0602 |
| Travel Immunization Detox 6033travel immunization detox | Oyster shell calcium carbonate, Crude 3 [hp_X]/59mL + 15 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-6033 |
| Twinrixhepatitis a and hepatitis b (recombinant) vaccine | Hepatitis a virus strain hm175 antigen (Formaldehyde inactivated) 720 [iU]/mL; Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular | A-S Medication Solutions | 50090-1645 |
| Twinrixhepatitis a and hepatitis b (recombinant) vaccine | Hepatitis a virus strain hm175 antigen (Formaldehyde inactivated) 720 [iU]/mL; Hepatitis b virus subtype adw2 hbsag surface protein antigen 20 ug/mL | Injection, SuspensionIntramuscular | GlaxoSmithKline Biologicals SA | 58160-815 |
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | Sanofi Vaccines US Inc. | 49281-790 |
| Typhim Visalmonella typhi ty2 vi polysaccharide antigen | Salmonella typhi ty2 vi polysaccharide antigen 25 ug/.5mL | Injection, SolutionIntramuscular | A-S Medication Solutions | 50090-1493 |
| Vaccinosis Nosode 4004vaccinosis nosode | Oyster shell calcium carbonate, Crude 6 [hp_X]/59mL + 8 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-4004 |
| Vaccistatbaptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, alumina, antimonium tartaricum, mezereum, natrum muriaticum, mercurius solubilis, silicea, thuja occidentalis, malandrinum, variolinum | Baptisia tinctoria root 3 [hp_X]/mL + 11 more ingredients | LiquidOral | Energique, Inc. | 44911-0540 |
| Vaccistatbaptisia tinctoria, echinacea (angustifolia), hydrastis canadensis, alumina, antimonium tartaricum, mezereum, natrum muriaticum, mercurius solubilis, silicea, thuja occidentalis, malandrinum, variolinum | Baptisia tinctoria root 3 [hp_X]/mL + 11 more ingredients | LiquidOral | Energique, Inc. | 44911-0633 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4095 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4096 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 25 [iU]/.5mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4831 |
| Vaqtahepatitis a vaccine, inactivated | Hepatitis a virus strain cr 326f antigen (Formaldehyde inactivated) 50 [iU]/mL | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4841 |
| Varivaxvaricella virus vaccine live | Varicella-zoster virus strain oka/merck live antigen 1350 [PFU]/.5mL | Injection, Powder, Lyophilized, For suspensionSubcutaneous | Merck Sharp & Dohme LLC | 0006-4827 |
| Vaxelisdiphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, haemophilus b conjugate and hepatitis b vaccine | Corynebacterium diphtheriae toxoid antigen (Formaldehyde inactivated) 15 [Lf]/.5mL + 10 more ingredients | Injection, SuspensionIntramuscular | MSP Vaccine Company | 63361-243 |
| Vaxneuvancepneumococcal 15-valent conjugate vaccine crm197 protein adsorbed | Streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen 2 ug/.5mL + 15 more ingredients | Injection, SuspensionIntramuscular | Merck Sharp & Dohme LLC | 0006-4329 |
| Vir Combinationinfluenzinum (2021-2022), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode | Influenza a virus a/victoria/2570/2019 ivr-215 (H1n1) antigen (Formaldehyde inactivated) 12 [hp_X]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2040 |
| Vir Combinationinfluenzinum (2022-2023), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode | Influenza a virus a/victoria/2570/2019 ivr-215 (H1n1) antigen (Uv, Formaldehyde inactivated) 12 [hp_X]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2062 |
| Vir Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2022-2023) | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 10 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2123 |
| Vir Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum (2023-2024) | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2193 |
| VIR Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 dna, herpes simplex virus 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex i, herpes simplex ii nosode, human herpesvirus 6a, influenzinum | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2357 |
| VIR Combinationadenoviren nosode, cytomegalovirus nosode, herpes simplex virus 1 and 2 dna, epstein-barr virus nosode, hepatitis b nosode, herpes simplex i and ii nosode, human herpesvirus 6a, human herpesvirus 6b, influenzinum | Human adenovirus e serotype 4 strain cl-68578 antigen 12 [hp_C]/mL + 11 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2539 |
| Viral Immune Stimulator 6017viral immune stimulator | Sodium chloride 3 [hp_X]/59mL + 19 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-6017 |
| Virexasclepias tuberosa, echinacea purpurea, trifolium pratense, natrum muriaticum, phytolacca decandra, euphrasia officinalis, lac vaccinum (nspc), thuja occidentalis, calcarea arsenicica, camphora, influenzinum, cytomegalovirus nosode, morbillinum, variolinum, coxsackie a2 nosode, coxsackie a3 nosode, coxsackie a4 nosode, coxsackie a7 nosode, coxsackie b1 nosode, coxsackie b3 nosode, coxsackie b5 nosode, coxsackie a5 nosode, adenoviren nosode, epstein barr virus nosode, coxsackie b4 nosode | Asclepias tuberosa root 3 [hp_X]/mL + 25 more ingredients | SprayOral | Nutritional Specialties, Inc. | 83027-0050 |